AGH
Pharmaceuticals, Biotechnology & Life Sciences
Althea Group Holdings
- Short interest
- 0.00%
- −0.98 pp 30d
- as of 6 Nov 2024
- Reported shorts
- 20K
- Shares on issue
- 405.332M
Althea Group Holdings (AGH) company profile
Profile, insiders and operations
Company
AI-generated research profile of Althea Group Holdings
medicinal cannabis
healthcare
pharmaceuticals
biotechnology
life sciences
Althea Group Holdings Limited operates in the medicinal cannabis industry, focusing on the production and distribution of cannabis-based medicines in Australia and international markets. The company leverages its licenses to import, cultivate, and manufacture medicinal cannabis, catering to a growing demand for healthcare solutions in this sector. Althea aims to enhance patient access through diversified product offerings and strategic partnerships.
Director trades
17 trades recorded
AGH intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required